TGF-β1 Gene Polymorphisms Are Not Associated with Risk of Radiation-induced Pneumonitis in Chinese
N. Bi,L. Zhang,L. Zhao,M. Yang,W. Ji,D. Yu,D. Lin,L. Wang
DOI: https://doi.org/10.1016/j.ijrobp.2010.07.126
2010-01-01
Abstract:Purpose/Objective(s)Transforming growth factor-β1 (TGF-β1) is a candidate for the pathogenesis of radiation-induced pneumonitis (RP). We attempted to elucidate the association between TGF-β1 genetic variations and risk of RP among Chinese patients with non-small-cell lung cancer (NSCLC).Materials/MethodsBetween 2004 and 2007, 179 Chinese NSCLC patients receiving definitive thoracic irradiation were recruited. The Common Terminology Criteria for Adverse Events v3.0 was used to grade RP. Three variants of TGF-β1 gene, C-509T (rs1800469), T869C (rs1800470), and G915C (rs1800471) were genotyped using polymerase chain reaction-restriction fragment length polymorphism method or direct PCR sequencing. Plasma TGF-β1 level was measured using an enzyme-linked immunosorbent assay. Cox regression analysis was used to determine factors associated with RP risk. Mann-Whitney U test was used for skewed variables such as circulating TGF-β1 levels.ResultsAmong all the patients, 145 were male and 34 were female. The median age was 61 years. Forty-nine patients received RT alone, and 130 received combined platinum-based chemoradiotherapy. After a median follow-up of 22 months, 28 patients (15.6%) developed ≥grade 2 RP. In our Chinese patients, the frequencies of CC genotype in C-509T, GG in G915C, or TT in T869C were 25.9%,100%, and 29.8%, respectively, which were significant different from those observed in Whites, with the incidences of 61.3% (p < 0.001), 87.9% (p < 0.001), and 31.9% (p = 0.009), respectively. No significant associations were found among the genotypes and RP risk for C-509T and T869C SNPs (p = 0.81 and p = 0.84, respectively). The mean pre-RT TGF-β1 level was 4.06 ± 0.46ng/mL, and the mean during-RT TGF-β1 level was 3.71 ± 0.44ng/mL. No significant differences in pre-RT TGF-β1 levels for C-509T and T869C SNPs were observed between different genotypes (p = 0.95 and p = 0.83, respectively). The same analyses were performed for during-RT TGF-β1 levels, and the results were the same (p = 0.99 and p = 0.47, respectively).ConclusionsThe genotype distributions of the three TGF-β1 variants are significantly dependent on ethnicity. Different from previous reports involving Whites, polymorphisms of the TGF-β1 gene do not represent a genetic predisposition to RP susceptibility in Chinese. In addition, neither of the two frequent polymorphisms in Chinese (C-509T and T869C), have been found to be associated with the circulating level of the TGF-β1 gene product. Purpose/Objective(s)Transforming growth factor-β1 (TGF-β1) is a candidate for the pathogenesis of radiation-induced pneumonitis (RP). We attempted to elucidate the association between TGF-β1 genetic variations and risk of RP among Chinese patients with non-small-cell lung cancer (NSCLC). Transforming growth factor-β1 (TGF-β1) is a candidate for the pathogenesis of radiation-induced pneumonitis (RP). We attempted to elucidate the association between TGF-β1 genetic variations and risk of RP among Chinese patients with non-small-cell lung cancer (NSCLC). Materials/MethodsBetween 2004 and 2007, 179 Chinese NSCLC patients receiving definitive thoracic irradiation were recruited. The Common Terminology Criteria for Adverse Events v3.0 was used to grade RP. Three variants of TGF-β1 gene, C-509T (rs1800469), T869C (rs1800470), and G915C (rs1800471) were genotyped using polymerase chain reaction-restriction fragment length polymorphism method or direct PCR sequencing. Plasma TGF-β1 level was measured using an enzyme-linked immunosorbent assay. Cox regression analysis was used to determine factors associated with RP risk. Mann-Whitney U test was used for skewed variables such as circulating TGF-β1 levels. Between 2004 and 2007, 179 Chinese NSCLC patients receiving definitive thoracic irradiation were recruited. The Common Terminology Criteria for Adverse Events v3.0 was used to grade RP. Three variants of TGF-β1 gene, C-509T (rs1800469), T869C (rs1800470), and G915C (rs1800471) were genotyped using polymerase chain reaction-restriction fragment length polymorphism method or direct PCR sequencing. Plasma TGF-β1 level was measured using an enzyme-linked immunosorbent assay. Cox regression analysis was used to determine factors associated with RP risk. Mann-Whitney U test was used for skewed variables such as circulating TGF-β1 levels. ResultsAmong all the patients, 145 were male and 34 were female. The median age was 61 years. Forty-nine patients received RT alone, and 130 received combined platinum-based chemoradiotherapy. After a median follow-up of 22 months, 28 patients (15.6%) developed ≥grade 2 RP. In our Chinese patients, the frequencies of CC genotype in C-509T, GG in G915C, or TT in T869C were 25.9%,100%, and 29.8%, respectively, which were significant different from those observed in Whites, with the incidences of 61.3% (p < 0.001), 87.9% (p < 0.001), and 31.9% (p = 0.009), respectively. No significant associations were found among the genotypes and RP risk for C-509T and T869C SNPs (p = 0.81 and p = 0.84, respectively). The mean pre-RT TGF-β1 level was 4.06 ± 0.46ng/mL, and the mean during-RT TGF-β1 level was 3.71 ± 0.44ng/mL. No significant differences in pre-RT TGF-β1 levels for C-509T and T869C SNPs were observed between different genotypes (p = 0.95 and p = 0.83, respectively). The same analyses were performed for during-RT TGF-β1 levels, and the results were the same (p = 0.99 and p = 0.47, respectively). Among all the patients, 145 were male and 34 were female. The median age was 61 years. Forty-nine patients received RT alone, and 130 received combined platinum-based chemoradiotherapy. After a median follow-up of 22 months, 28 patients (15.6%) developed ≥grade 2 RP. In our Chinese patients, the frequencies of CC genotype in C-509T, GG in G915C, or TT in T869C were 25.9%,100%, and 29.8%, respectively, which were significant different from those observed in Whites, with the incidences of 61.3% (p < 0.001), 87.9% (p < 0.001), and 31.9% (p = 0.009), respectively. No significant associations were found among the genotypes and RP risk for C-509T and T869C SNPs (p = 0.81 and p = 0.84, respectively). The mean pre-RT TGF-β1 level was 4.06 ± 0.46ng/mL, and the mean during-RT TGF-β1 level was 3.71 ± 0.44ng/mL. No significant differences in pre-RT TGF-β1 levels for C-509T and T869C SNPs were observed between different genotypes (p = 0.95 and p = 0.83, respectively). The same analyses were performed for during-RT TGF-β1 levels, and the results were the same (p = 0.99 and p = 0.47, respectively). ConclusionsThe genotype distributions of the three TGF-β1 variants are significantly dependent on ethnicity. Different from previous reports involving Whites, polymorphisms of the TGF-β1 gene do not represent a genetic predisposition to RP susceptibility in Chinese. In addition, neither of the two frequent polymorphisms in Chinese (C-509T and T869C), have been found to be associated with the circulating level of the TGF-β1 gene product. The genotype distributions of the three TGF-β1 variants are significantly dependent on ethnicity. Different from previous reports involving Whites, polymorphisms of the TGF-β1 gene do not represent a genetic predisposition to RP susceptibility in Chinese. In addition, neither of the two frequent polymorphisms in Chinese (C-509T and T869C), have been found to be associated with the circulating level of the TGF-β1 gene product.